Trial Details

COMPLETED
Basic Information
Clinical ID c1239
Identifier NCT01829321
Trial Title Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: GLPG0974|DRUG: Placebo
Participant Information
Sponsor Galapagos NV
City Bonheiden
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-04-13
Primary Completion Date 2025-04-14
Completion Date 2025-04-14